New agreement to facilitate genetic diagnosis of hereditary retinal dystrophies

FHS
July 17, 2023
12:21 pm

An agreement between the University of Barcelona spin-off DBGen Ocular Genomics and the company Novartis España will enable the genetic identification of retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) in affected patients.

Vim CEO Talks Solving the Rising Tide of Healthcare Claim Denials

Oron Afek, CEO of Vim The U.S. healthcare system is grappling with a surge in claim denials and prior authorization requirements, creating significant challenges for

November 7, 2024

Negotiations on the Acquisitions of Almost All Assets – Biotech Investments

Epigenomics AG / Key word(s): Miscellaneous Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets 12-Jun-2023 / 10:21 CET/CEST Disclosure of an inside information

June 13, 2023

Sapio Sciences and CREO Announce Strategic Partnership

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.